References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Haganetal(2000)CharacterizationofSB-269970-A,aselective5-HT7receptorantagonist.Br.J.Pharmacol.130539PMID:10821781
Koganetal(2002)DR4004,aputative5-HT7receptorantagonist,alsohasfunctionalactivityatthedopaminereceptor.Eur.J.Pharmacol.449105PMID:12163113
Lovelletal(2000)Anovel,potent,andselective5-HT7antagonist:(R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol(SB-269970)J.Med.Chem.43342PMID:10669560
Keywords:SB269970hydrochloride,supplier,Potent,selective,5-HT7,antagonists,Brain,penetrant,SEROtonin,Receptors,5-Hydroxytryptamine,SB269970,hydrochloride,GlaxoSmithKline,GSK,5-HT7,Receptors,5-HT7,Receptors,TocrisBioscience